Definition of Acute Respiratory Distress Syndrome

Ñamendys‐Silva, Silvio A.; Hernández-Garay, Marisol

doi:10.1001/2012.jama.11889

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Domestic data showed that mortality of severe COVID-19 patients was about 8-29% [6,7]. The most important reason resulting in multiple organ dysfunction syndrome (MODS) or even death in COVID-19 is that acute respiratory distress syndrome (ARDS) happened, which was diagnosed by tachypnea with respiratory frequency of ≥30 beats per minute (bpm), arterial oxygen pressure/ fraction of inspiration O 2 (P/F) ＜300 mmHg [with positive end-expiratory pressure (PEEP) of ≥5 cmH 2 O], with infiltrates in bilateral lung which was unexplained by cardiogenic pulmonary edema or other lung diseases [8]. In severe ARDS (with P/F ＜100 mmHg), the typical management comprises invasive mechanical ventilation, among which consists of small tidal volume, plateau pressure control, prone positioning, etc.…”

Section: Introductionmentioning

confidence: 99%

Sequential application with NIV and high-flow nasal cannula oxygen therapy in the treatment of critically ill patient with severe COVID-19: A case report

Shen¹,

Liu²

2020

Int J Case Rep Images

View full text Add to dashboard Cite

Introduction:To summarize the experiences of sequential application with noninvasive (NIV) and highflow nasal cannula oxygen (HFNCO) therapy in the treatment for critically ill patient with severe COVID-19. Case Report: In a mixed Intensive Care Unit, a medical university affiliated hospital in Guizhou Province, China, sequential application with NIV and HFNCO was used in the treatment for a COVID-19 patient with severe acute respiratory distress syndrome (ARDS), and the vital signs and laboratory results were dynamically monitored. A female patient with severe COVID-19 and severe acute respiratory failure was completely recovered from the disease by sequential application with NIV mechanical ventilation and HFNCO therapy. Conclusion: From our limited experience of the case report, NIV and HFNCO could cautiously be used in severe patient with ARDS in condition of close and dynamic monitoring.

show abstract

Section: Introductionmentioning

confidence: 99%